Results 31 to 40 of about 13,025 (170)

532‐nm KTP Laser Treatment of Epidermal Growth Factor Receptor Inhibitor–Associated Paronychia: A Case Report

open access: yesLasers in Surgery and Medicine, EarlyView.
ABSTRACT Objectives Paronychia is a common and often painful cutaneous adverse event of epidermal growth factor receptor inhibitor therapy that can impair function and quality of life. We report the first known case of amivantamab‐associated paronychia successfully treated with 532‐nm potassium‐titanyl‐phosphate laser.
Emilee M. Dreifus   +2 more
wiley   +1 more source

Avaliação econômica do tratamento do galucoma com colírios de associações fixas de timolol com análagos de prostaglandina em Florianópolis (SC) [PDF]

open access: yes, 2010
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Gonzales, Fernando Henrique Zanardo
core  

Timolol

open access: yes, 2007
Timolol is a non-selective, beta adrenoceptor antagonist at beta-1 and beta-2 adrenoceptors. It lacks the partial agonist and local anesthetic properties that some drugs in this class have.
Donald Hoover, Hoover, Donald
core   +1 more source

Recent progress on the development of hydrogel‐based microneedles for transdermal drug delivery

open access: yesVIEW, EarlyView.
This study provides a comprehensive and up‐to‐date analysis of recent progress in HMN technology, covering fundamental transdermal delivery mechanisms and design principles, biomaterials used in HMN fabrication, drug loading and release strategies, and emerging therapeutic applications.
Mohammad Muhtasim Ittisaf   +5 more
wiley   +1 more source

A comparative evaluation of efficiency of fixed combination hypotensives for the treatment of primary open-angle glaucoma

open access: yesРоссийский офтальмологический журнал, 2018
Purpose. To compare hypotensive efficiency and safety of fixed combinations of drugs treating primary open-angle glaucoma (POAG). Material and methods.
F. A. Bakhritdinova   +3 more
doaj   +1 more source

TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)—A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial

open access: yesPharmaceutics, 2022
To date, there is no approved local therapeutic agent for the treatment of epistaxis due to hereditary hemorrhagic telangiectasia (HHT). Several case reports suggest the topical use of timolol.
Kornelia E. C. Andorfer   +8 more
doaj   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont   +5 more
wiley   +1 more source

Traction suture fixation technique using a capsular tension ring fragment for severe lens displacement during cataract surgery in dogs

open access: yesVeterinary Ophthalmology, Volume 28, Issue 2, Page 197-206, March 2025.
Abstract Objectives To describe the traction suture fixation technique for severely displaced lenses (≥180°) using a capsular tension ring (CTR) fragment during cataract surgery in dogs, and to retrospectively investigate its clinical outcomes. Animals Studied Eight dogs (nine eyes). Procedures The medical records of dogs with severe lens displacement (
Shinya Fukumoto, Tomomi Minamoto
wiley   +1 more source

Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs

open access: yesOphthalmology and Therapy, 2020
Introduction This study was aimed to compare ocular tissue distribution and systemic exposure of brimonidine and timolol after single topical administration to rabbits of fixed-combination ophthalmic solution of 0.1% brimonidine tartrate and 0.5% timolol
Gen Suzuki   +5 more
doaj   +1 more source

A comparative study on the efficacy and cost-effectiveness of latanoprost and timolol in glaucoma

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2020
Background: Glaucoma is a chronic, progressive optic neuropathy which leads to optic nerve damage and loss of visual function. Elevated intraocular pressure (IOP) is the most important and only modifiable risk factor.
Iram Shaifali   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy